腸内フローラの形成と疾患

出版社： 医薬出版
著者：
発行日： 2018-08-25
分野： 基礎医学  >  医動物(寄生虫)
ISBN： 9784990673963
電子書籍版： 2018-08-25 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

5,280 円(税込)

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

3,168 円(税込)

購入する

目次

  • はじめに

    特別講演１ 「先天性外科疾患患児における腸内細菌叢形成異常と
    　　　　　　　シンバイオティクス療法による腸内細菌叢コントロールの効果」

    特別講演２ 「失われていく細菌叢と世界的な慢性疾患の蔓延に関する理論」

    講　　演１ 「特定の乳酸菌がマウスの生後成長ダイナミクスおよび
    　　　　　　　低栄養下における成長ホルモン軸形成に与える影響」

    講　　演２ 「ヒト母乳オリゴ糖を介した乳児腸管における
    　　　　　　　ビフィズスフローラ形成機構」」

    講　　演３ 「乳児腸内フローラの形成に影響を与えるビフィズス菌の
    　　　　　　　遺伝特性と定着意義」

    講　　演４ 「アジア　マイクロビオーム　プロジェクト：アジア人の食と健康の
    　　　　　　　インターフェースとしての腸内フローラの理解に向けて」

    講　　演５ 「非感染症におけるプロバイオティクスの効果

    総合討論

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

はじめに

P.6 掲載の参考文献
1) 神谷茂 : 腸内細菌叢の形成と役割, 成人病と生活習慣病, 45 : 1462-1468, 2015
Medical*Online
2) Bourlioux P, Koletzko B, Guamer F, Braesco V : The intestine and its microflora are partners for the protection of the host : report on the Danone Symposium "The Intelligent Intestine" held in Paris, June 14, 2002. Am J Clin Nutr 78 : 675-683, 2003
 
3) Mitsuoka T, Hayakawa K. The fecal flora in man. I. Composition of the fecal flora of various age groups. Zbl Bakt Orig A. 223 : 333-342, 1973
 
4) Mitsuoka T : Establishment of intestinal bacteriology. Biosci Mirob Food Health 33 : 99-116, 2014
 
5) Blaser MJ, Dominguez-Bello MG : The human microbiome before birth. Cell Host Microbe 20 : 558-560, 2016
PubMed
6) 神谷茂 : 抗菌薬と腸内マイクロビオータ, 日本小児科医会会報 55 : 14-19, 2018
Medical*Online
7) Blaser MJ : Antibiotic use and its consequences for the normal micribiome. Science 352 : 544-545, 2016
PubMed
8) Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, Lieber A, Wu F, Perez-Perez GI, Chen Y, Schweizer W, Zheng X, Contreras M, Dominguez-Bello MG, Blaser MJ : Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med 8 (343) : 343ra82, 2016
 
9) Matsuki T, Yahagi K, Mori H et al. : A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun 7 : 11939, 2016
 

特別講演1. 先天性外科疾患患児における腸内細菌叢形成異常とシンバイオティクス療法による腸内細菌叢コントロールの効果

P.15 掲載の参考文献
1) Kanamori Y, Hashizume K, Sugiyama M, Morotomi M, Yuki N. : Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome A novel synbiotics therapy for intestinal failure. Dig Dis Sci 46 ; 2010-2016, 2001.
 
2) Kanamori Y, Hashizume K, Sugiyama M, Morotomi M, Yuki N, Tanaka R. : A novel synbiotic therapy dramatically improved the intestinal function of a pediatric patient with laryngotracheo-esophageal cleft (LTEC) in the intensive care unit. Clin Nutr 21 : 527-530, 2002.
 
3) Kanamori Y, Hashizume K, Kitano Y, Tanaka Y, Morotomi M, Yuki N, Tanaka R. : Anaerobic dominant flora was reconstructed by synbiotics in an infant with MRSA enteritis. Pediatr Int 45 : 359-362, 2003.
 
4) Kanamori Y, Sugiyama M, Hashizume K, Yuki N, Morotomi M, Tanaka R. : Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg 39 : 1686-1692, 2004.
PubMed
5) Kanamori Y, Sugiyama M, Goishi K Kano H, Yuki N, Takahashi T, Morotomi M, Tanaka R. : Abnormal intestinal microbiota in pediatric surgical patients and the effects of a newly designed synbiotic therapy. Int J Prob Preb 1 : 149-160, 2006.
 
6) Kanamori Y, Iwanaka T, Sugiyama M, Komura M, Takahashi T, Yuki N, Morotomi M, Tanaka R. : Early use of probiotics is an important therapy in infants with severe congenital anomaly. Pediatr Int 52 ; 362-367, 2010.
PubMed

特別講演2. 失われていく細菌叢と世界的な慢性疾患の蔓延に関する理論

P.19 掲載の参考文献
1) Blaser MJ. Who are we Indigenous microbes and the ecology of human diseases. EMBO Reports 2006 ; 7 : 956-960.
PubMed
2) Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota Nature Reviews Microbiology. 2009 ; 7 : 887-894. [PMID : 19898491]
 
3) Blaser MJ. The theory of disappearing microbiota and the epidemics of chronic diseases. Nature Reviews Immunology 2017 ; 17 : 461-463, doi : 10.1038/nri. 2017. 77
 
4) Clemente JC, Pehrsson E, Blaser MJ, Sandhu K, Gao Z, Wang B, Magris M, Hidalgo G, Contreras M, Noya-Alarcon O, Lander O, McDonald J, Cox M, Walter J, Oh P, Ruiz JF, Rodriguez S, Shen N, Song SJ, Metcalf J, Knight R, Dantas G, Dominguez-Bello M. The microbiome of uncontacted Amerindians. Science Advances 2015 ; 1 : e1500183. doi : 10.1126/sciadv. 1500183.
 
5) Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science 2016 ; 352 : 544-545.
PubMed
6) Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, Li H, Alekseyenko AV, Blaser, MJ. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012 ; 488 : 621-626. [PMID : 22914093]
 
7) Cox LM, Cho I, Young SA, Anderson WHK, Waters BJ, Hung SC, Gao Z, Mahana D, Bihan M, Alekseyenko AV, Methe B, Blaser MJ. The non-fermentable dietary fiber hydroxpropyl methylcellulose modulates intestinal microbiota. FASEB J 2013 ; 27 : 692-702. [PMID : 23154883]
 
8) Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, Kim S, Li H, Gao Z, Mahana D, Zarate Rodriguez JG, Rogers AB, Robine N, Loke P, Blaser MJ, Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014 ; 158 : 705-721.
 
9) Nobel YR, Cox LM, Kirigin FF, Bokulich NA, Yamanishi S, Teitler I, Chung J, Sohn J, Barber C, Goldfarb DS, Raju K, Abubucker S, Zhou Y, Ruiz VE, Li H, Mitreva M, Alekseyenko AV, Weinstock GM, Sodergren E, Blaser MJ. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nature Communications 2015 ; 6 : 7486. doi : 10.1038/ncomms8486.
 
10) Mahana D, Trent CM, Kurtz Z, Bokulich NA, Battaglia T, Chung J, Muller CL, Li H, Bonneau RA, Blaser MJ. Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet. Genome Medicine 2016 ; 8 : 48.
PubMed
11) Livanos AE, Greiner TU, Vangay P, Pathmasiri W, Stewart D, McRitchie S, Li H, Chung J, Sohn J, Kim S, Gao Z, Barber C, Kim J, Ng S, Rogers AB, Sumner S, Zhang X-S, Cadwell K, Knights D, Alekseyenko A, Backhed F, Blaser MJ. Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nature Microbiology 2016 ; 1 : 16140. doi : 10.1038/nmicrobiol. 2016. 140.
 
12) Ruiz VE, Battaglia T, Kurtz ZD, Bijnens L, Ou A, Engstrand I, Zheng X, Iizumi T, Mullins BJ, Muller CL, Cadwell K, Bonneau R, Perez Perez GI, Blaser MJ. A single early-in-life macrolide course has lasting effects on murine microbial network topology and immunity. Nature Communications 2017 ; 8, 518 doi : 10.1038/s41467-017-00531-6.
 
13) Schulfer A, Battaglia T, Alvarez Y, Bijnens L, Ruiz VE, Ho M, Robinson S, Ward W, Cox LM, Rogers AB, Knights D, Sartor RB, Blaser MJ. Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nature Microbiology 2017 ; doi : 10.1038/s41564-017-0075-5.
 
14) Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Chen H, Berger KI, Goldring RM, Rom WN, Blaser MJ, Weiden MD. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 2013 ; 1 : 19-25.
 
15) Segal LN, Clemente JC, Tsay J-CJ, Koralov SB, Keller BC, Wu BG, Li Y, Shen N, Ghedin E, Morris A, Diaz P, Huang L, Wikoff WR, Ubeda C, Artacho A, Rom WN, Sterman DH, Collman RG, Blaser MJ, Weiden MD. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nature Microbiology 2016 ; 1 (16031) : 1-11. doi : 10.1038/nmicrobiol. 2016. 31.
 
16) Segal L, Clemente JC, Wu BG, Wikoff WR Gao Z, Li Y, Ko J, Rom WN, Blaser MJ, Weiden MD. Randomized, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. Thorax 2016 ; pii : thoraxjnl-2016-208599. doi : 10.1136/thoraxjnl-2016-208599.
 
17) Stokholm J, Blaser MJ, Thorsen J, Rasmussen MA, Waage J, Vinding RK, Schoos A-MM, Kunee A, Fink NR, Chawes BL, Bennelykke K, Brejnrod AD, Mortensen MS, Abu Al-Soud W, Sorensen SJ, Bisgaard H. Maturation of the gut microbiome and risk of asthma in childhood. Nature Communications 2018 ; 9 : 141 (#2905542) doi : 10.1038/s41467-017-02573-2.
 
18) Paulino LC, Tseng CH, Strober BE, Blaser MJ. Molecular analysis of fungal microbiota in superficial human skin in health and in psoriatic lesions. Journal of Clinical Microbiology 2006 : 44 : 2933-2941. [PMID : 16891514]
 
19) Gao Z, Tseng C, Strober BE, Pei Z, Blaser MJ. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS ONE 2008 ; 3 : e2719. [PMID : 18648509]
 
20) Alekseyenko AV, Perez-Perez GI, D'Souza A, Strober B, Gao Z, Bihan M, Li K, Methe B, Blaser MJ. Community differentiation of the cutaneous microbiota in psoriasis. Microbiome 2013 ; 1 : 31-8.
 
21) Redel H, Gao Z, Li H, Alekseyenko AV, Zhou Y, Perez-Perez GI, Weinstock G, Sodergren E, Blaser MJ. Quantitation and composition of cutaneous microbiota in diabetic and non-diabetic men. Journal of Infectious Diseases 2013 ; 207 : 1105-1114.
 
22) Statnikov A, Alekseyenko AV, Li Z, Henaff M, Perez-Perez GI, Blaser MJ, Aliferis CF. Microbiomic signatures of Psoriasis : feasibility and methodology comparison. Nature Scientific Reports 2013 ; 3 : 2620.
 
23) Horton J, Gao Z, Sullivan M, Shopsin B, Perez-Perez GI, Blaser MJ. The cutaneous microbiome in outpatients presenting acutely with skin abscesses. Journal of Infectious Disease 2015 ; 211 : 1895-904. doi : 10.1093/infdis/jiv003.
 
24) Gonzalez ME, Schaffer JV, Orlow SJ, Gao, Li H, Alekseyenko AV, Blaser MJ. Cutaneous microbiome effects of fluticasone proprionate cream and adjunctive bleach baths in childhood atopic dermatitis. Journal of the American Academy of Dermatology 2016 ; 75 : 481-493.
 
25) Kienesberger-Feist S, Cox LM, Livanos A, Zhang X, Chung J, Perez-Perez G ; Gorkiewicz G, Zechner E, Blaser MJ. Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Reports 2016 ; 14 : 1395-1407.
 
26) Blaser MJ, Chen Y. A new gastric cancer among us. (editorial) JNCI 2018 ; doi 10.1093/jnci/djx279
 
27) Barnett C, Nazzal L, Goldfarb DS, Blaser MJ. The presence of Oxalobacter formigenes in the microbiome of healthy young adults. Journal of Urology 2015 ; 195 : 499-506.
PubMed
28) Liu M, Koh H, Kurtz ZD, Battaglia T, PeBenito A, Li H, Nazzal L, Blaser MJ. Oxalobacter formigenes-associated host features and microbial community structures examined using the American Gut Project. Microbiome. 2017 ; 5 (1) : 108.
PubMed
29) Nazzal L, Roberts J, Singh P, Jhawar S, Matalon A, Gao Z, Holzman R, Liebes L, Blaser MJ, Lowenstein J. Microbiome perturbation by oral vancornycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in ESRD. Nephrology Dialysis Transplantation 2017 : gfx029.
 
30) Plottel CP, Blaser MJ. Microbiome and malignancy. Cell Host & Microbe 2011 ; 10 : 324-335. [PMID : 22018233]
 
31) Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor-positive female breast cancer. Journal of the National Cancer Institute 2016 ; 108 (8). pii : djw029. doi : 10.1093/jnci/djw029.
 
32) Blaser MJ. The past and future biology of the human microbiome in an age of extinctions. Cell 2018 ; in press.
 
33) Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, Lieber A, Wu F, Perez-Perez GI, Chen Y, Schweizer W, Zheng X, Contreras M, Dominguez-Bello MG, Blaser MJ. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Science Translational Medicine 2016 ; 8 (343) : 343ra82. doi : 10.1126/scitranslmed. aad7121.
 
34) Van Hartigh L, Gao Z, Goospeed L, Wang S, Das A, CF Burant Chait A, Blaser MJ. Obese mice losing weight due to 10, 12 conjugated linoleic acid supplementation or food restriction harbor distinct gut microbiota. Journal of Nutrition 2018 ; in press.
 
35) Cox LM, Sohn J, Tyrrell KL, Citron DM, Lawson PA, Patel NB, Iizumi T, Perez-Perez GI, Goldstein EJC, Blaser MJ. Description of two novel members of the family Erysipelotrichaceae : Heibacterium valens gen. nov., sp. nov. and Dubosiello newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibacterium rodentium. International Journal of Systematic and Evolutionary Microbiology 2017 ; 67 : 1247-1254
 
36) Blaser MJ, Webb GF. Host demise as a beneficial function of indigenous microbiota in human hosts. mBio 2014 ; 5 : 1-9. doi : 10.1128/mBio. 02262-14.
 
37) Koh H, Blaser MJ, Li H. A powerful microbiome-based association test and a microbial taxa discovery framework for comprehensive association mapping. Microbiome 2017 ; 5 : 45.
 

講演1. 特定の乳酸菌がマウスの生後成長ダイナミクスおよび低栄養下における成長ホルモン軸形成に与える影響

P.27 掲載の参考文献
1) Dubos, RJ., Mirage of Health : Utopias, Progress, and Biological Change. 1959, New York : Harper & Brothers.
 
2) McFall-Ngai, M., et al., Animals in a bacterial world, a new imperative for the life sciences. Proceedings of the National Academy of Sciences of the United States of America, 2013. 110 (9) : p. 3229-36.
 
3) Janssen, A. W. and S. Kersten, Potential mediators linking gut bacteria to metabolic health : a critical view. J Physiol, 2017. 595 (2) : p. 477-487.
 
4) Backhed, F., et al., Host-bacterial mutualism in the human intestine. Science, 2005. 307 (5717) : p, 1915-20.
 
5) Stappenbeck, T. S., L. V. Hooper, and J. I. Gordon, Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA, 2002. 99 (24) : p. 15451-5.
 
6) Brugiroux, S. et al., Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium. Nat Microbiol, 2016. 2 : p. 16215.
PubMed
7) Kozakova, H., et al., Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization. Cell Mol Immunol, 2016. 13 (2) : p. 251-62.
 
8) Tlaskalova-Hogenova, H., et al., The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer : contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol, 2011. 8 (2) : p. 110-20.
 
9) Faith, J. J., et al., Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science, 2011. 333 (6038) : p. 101-4.
 
10) Leulier, F., et al., Integrative physiology : At the crossroads of nutrition, microbiota, animal physiology, and human health. Cell Metab, 2017. 25 (3) : p. 522-534.
 
11) Black, R. E., et al., Maternal and child undernutrition : global and regional exposures and health consequences. Lancet, 2008. 371 (9608) : p. 243-60.
 
12) Ahmed, T., S. Rahman, and A. Cravioto, Oedematous malnutrition. The Indian Journal of medical research, 2009. 130 (5) : p. 651-4.
 
13) Smith, M. I., et al., Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science, 2013. 339 (6119) : p. 548-54.
 
14) Subramanian, S., et al., Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature, 2014. 510 (7505) : p. 417-21.
 
15) Blanton, L. V., et al., Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science, 2016. 351 (6275).
PubMed
16) Gordon, J. I., et al., The human gut microbiota and undernutrition. Science translational medicine, 2012. 4 (137) : p. 137ps12.
 
17) Schwarzer, M., et al., Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science, 2016. 351 (6275) : p. 854-7.
 
18) Shin, S. C., et al., Drosophila microbiome modulates host developmental and metabolic homeostasis via insulin signaling. Science (New York, NY), 2011. 334 (6056) : p. 670-4.
 
19) Storelli, G., et al. Lactobacillus plantarum promotes Drosophila systemic growth by modulating hormonal signals through TOR-dependent nutrient sensing. Cell metabolism, 2011. 14 (3) : p. 403-14.
 
20) Breier, B. H., Regulation of protein and energy metabolism by the somatotropic axis. Domest Anim Endocrinol, 1999. 17 (2-3) : p. 209-18.
 
21) Hartman, M. L., JD. Veldhuis, and M. O. Thorner, Normal control of growth hormone secretion. Hormone research, 1993. 40 (1-3) : p. 37-47.
 
22) Bartke, A., L. Y. Sun, and V. Longo, Somatotropic signaling : trade-offs between growth, reproductive development, and longevity. Physiological reviews, 2013. 93 (2) : p. 571-98.
 
23) Fazeli, P. K. and A. Klibanski, Determinants of GH resistance in malnutrition. The Journal of endocrinology, 2014. 220 (3) : p. R57-65.
 
24) Gordon, H. A., Morphological and physiological characterization of germfree life. Annals of the New York Academy of Sciences, 1959. 78 (1) : p. 208-220.
 
25) Wostmann, B. S., Nutrition of the germfree mammal. Annals of the New York Academy of Sciences, 1959. 78 (1) : p. 175-182.
 
26) Schwarzer, M., et al., Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science (New York, NY), 2016. 351 (6275) : p. 854-7.
 
27) Schwarzer, M., M. Strigini, and F. Leulier, Gut microbiota and host juvenile growth. Calcif Tissue Int, 2017. doi. org/10.1007/s00223-017-0368-y
 

講演2. ヒト母乳オリゴ糖を介した乳児腸管におけるビフィズスフローラ形成機構

P.39 掲載の参考文献
1) Kau, A. L. et al. Human nutrition, the gut microbiome and the immune system. Nature 474, 327-336 (2011).
PubMed
2) 光岡知足編著. ビフィズス菌研究の歴史. 「ビフィズス菌の研究J. 日本ビフィズス菌センター (1994).
 
3) Gauhe, A. et al. Bifidus factor. IV. Preparations obtained from human milk. Arch. Biochem. Biophys. 48, 214-224 (1954).
PubMed
4) Glick, M. C. et al. Morphological changes of Lactobacillus bifidus var. pennsylvanicus produced by a cell-wall precursor. Biochim. Biophys. Acta 37, 361-363 (1960).
PubMed
5) Katayama, T. et al. Molecular cloning and characterization of Bifidobacterium bifidum 1, 2-alpha-L-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J. Bacteriol. 186, 4885-4893 (2004).
PubMed
6) Fujita, K. et al. Identification and molecular cloning of a novel glycoside hydrolase family of core 1 type O-glycan-specific endo-alpha-N-acetylgalactosaminidase from Bifidobacterium longum. J. Biol. Chem. 280, 37415-37422 (2005).
PubMed
7) Henrissat, B. & Davies, G. Structural and sequence-based classification of glycoside hydrolases. Curr. Opin. Struct. Biol. 7, 637-644 (1997).
PubMed
8) Katayama, T. et al. Novel bifidobacterial glycosidases acting on sugar chains of mucin glycoproteins. J. Biosci. Bioeng. 99, 457-465 (2005).
PubMed
9) Kitaoka, M. et al. Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl. Environ. Microbiol. 71, 3158-3162 (2005).
PubMed
10) Brand-Miller, J. C. et al. Digestion of human milk oligosaccharides by healthy infants evaluated by the lactulose hydrogen breath test. J. Pediatr. 133, 95-98 (1998).
PubMed
11) Gnoth, M. J. et al. Human milk oligosaccharides are minimally digested in vitro. J. Nutr. 130, 3014-3020 (2000).
PubMed
12) Urashima, T. et al. Oligosaccharides : Sources, properties and applications. Nova Science Publishers. (2011).
 
13) Asakuma, S. et al. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria, J. Biol. Chem. 286, 34583-34592 (2011).
PubMed
14) Kobata, A. Structures and application of oligosaccharides in human milk. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci. 86, 731-747 (2010).
PubMed
15) Matsuki, T. et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat. Commun. 7, 11939 (2016).
PubMed
16) Bunesova, et al. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Befidobacterium kashiwanohense. BMC Microbiol. 16, 248 (2016).
 
17) Garrido, D. et al. A novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in Bifidobacterium longum subsp. longum SC596. Sci. Rep. 6, 35045 (2016).
 
18) Katayama, T. Host-derived glycans serve as selected nutrients for the gut microbe : human milk oligosaccharides and bifidobacteria. Biosci. Biotechnol, Biochem. 80, 621-632 (2016).
PubMed
19) Sela, D. A. et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl. Acad. Sci. U. S. A. 105, 18964-9 (2008).
PubMed
20) James, K. et al. Bifidobacterium breve UCC2003 metabolises the human milk oligosaccharides lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways. Sci. Rep. 6, 38560 (2016).
PubMed
21) Odamaki, T. et al. Comparative genomics revealed genetic diversity and species/strain-level differences in carbohydrate metabolism of three probiotic bifidobacterial species. Int. J. Genomics 2015, 567809 (2015).
PubMed
22) Yoshida, E. et al. Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides. Glycobiology 22, 361-368 (2012).
 
23) Viborg, A. H. et al. Distinct substrate specificities of three glycoside hydrolase family 42 β-galactosidases from Bifidobacterium longum subsp. infantis ATCC 15697. Glycobiology 24, 208-216 (2014).
 
24) LoCascio, R. G. et al. Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization. Appl. Environ. Microbiol. 76, 7373-7381 (2010).
PubMed
25) Ashida, H. et al. Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 19, 1010-1017 (2009).
 
26) Kiyohara, M. et al. An exo-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. Glycobiology 21, 437-447 (2011).
PubMed
27) Wada, J. et al. Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl. Environ. Microbiol. 74, 3996-4004 (2008).
PubMed
28) Miwa, M. et al. Cooperation of β-galactosidase and β-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure. Glycobiology 20, 1402-1409 (2010).
 
29) Yamada, C. and Gotoh, A, et al. Molecular insight into evolution of symbiosis between breast-fed infants and a member of the human gut microbiome Bifidobacterium longum. Cell Chem. Biol. 24, 515-524. (2017).
 
30) Kato, K. et al. Age-related changes in the composition of gut Bifidobacterium species. Curr. Microbiol. 74, 987-995 (2017).
PubMed
31) Nishimoto, M. and Kitaoka, M. Practical preparation of lacto-N-biose I, a candidate for the bifidus factor in human milk. Biosci. Biotechnol. Biochem. 71, 2101-2104 (2007).
PubMed
32) Suzuki, R. et al. Structural and thermodynamic analyses of solute-binding protein from Bifidobacterium longum specific for core 1 disaccharide and lacto一N-biose I. J. Biol. Chem. 283, 13165-13173 (2008).
 
33) Katoh, T. et al. Identification and characterization of a sulfoglycosidase from Bifidobacterium bifidum implicated in mucin glycan utilization. 81, 2018-2027 (2017).
PubMed
34) Egan, M. et al. Identification and characterization of a glycosulfatase-encoding gene cluster in Bifidobacterium breve UCC2003. Appl. Environ. Microbiol. (2016).
 
35) Egan, M. et al. Metabolism of sialic acid by Bifidobacterium breve UCC2003. Appl. Environ. Microbiol. 80, 4414-26 (2014).
PubMed
36) Egan, M. et al. Cross-feeding by Bilfidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC Microbiol. 14, 282 (2014).
 
37) Turroni, F. et al. Glycan cross-feeding activities between bifidobacteria under in vitro conditions. Front. Microbiol. 6, 1-8 (2015).
 
38) Rios-Covian, D. et al. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol. Lett. 362, fnv176 (2015).
PubMed
39) Rakoff-Nahoum, S. et al. The evolution of cooperation within the gut microbiota. Nature 533, 255-259 (2016).
PubMed
40) Belzer, C. et al. Microbial metabolic networks at the mucus layerlead to diet-independent butyrate and vitamin B12 production by intestinal symbionts. MBio 8, e00770-17 (2017).
PubMed
41) Di Gioia, D. et al. Bifidobacteria : their impact on gut microbiota composition and their applications as probiotics in infants. 98, (2014).
PubMed
42) Kalliomaki, M. et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing J. Allergy Clin. Immunol. 107, 129-134 (2001).
 
43) Saavedra, J. M. et al. Feeding of Bifidobacterium bifidum and streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet (London, England) 344, 1046-1049 (1994).
 
44) Beena, A. and Prasad, V. Effect of yogurt and bifidus yogurt fortified with skim milk powder, condensed whey and lactose-hydrolysed condensed whey on serum cholesterol and triacylglycerol levels in rats. J. Dairy Res. 64, 453-457 (1997).
PubMed
45) Scholz-Ahrens, et al. Effects of prebiotics on mineral metabolism. Am. J. Cli. Nutr. 73, 459S-464S (2001).
 
46) Olszak, T. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. MBio 336, (2012).
 
47) Cox, L. M. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705-721 (2014).
 

講演3. 乳児腸内フローラの形成に影響を与えるビフィズス菌の遺伝特性と定着意義

P.51 掲載の参考文献
1) Kurokawa, K., Itoh, T., Kuwahara, T., Oshima, K., Toh, H., Toyoda, A., Takami, H., Morita, Y. K., Srivastava, T. P., Taylor, T. D., Noguchi, H., Mori, H., Ogura, Y., Ehrlich, D. S., Itoh, K., Takagi, T., Sakaki, Y., Hayashi, T. &Hattori, M. : Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 2007, 14 : 169-181
 
2) Yatsunenko, T., Rey, F. E., Manary, M. J. Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M. Hidalgo, G., Baldassano, R. N., Anokhin, A. P., Heath, A. C., Warner, B., Reeder, J., Kuczynski, J., Caporaso, J. G., Lozupone, C. A., Lauber, C., Clemente, J. C., Knights, D., Knight, R. & Gordon, J. I. : Human gut microbiome viewed across age and geography. Nature 2012, 486 : 222-227
 
3) Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., Angenent, L. T. & Ley, R. E. : Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U. S. A. 2011, 108 Suppl 1 : 4578-4585
 
4) Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A. & Brown, P. 0. : Development of the human infant intestinal microbiota. PLoS Biol. 2007, 5 : e177
 
5) Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Bjorkholm, B., Samuelsson, A., Hibberd, M. L, Forssberg, H. & Pettersson, S. : Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U. S. A. 2011, 108 : 3047-3052
 
6) Cox, L. M., Yamanishi, S., Sohn, J., Alekseyenko, A. V., Leung, J. M., Cho, I., Kim, S. G., Li, H., Gao, Z., Mahana, D., Zarate Rodriguez, J. G., Rogers, A. B., Robine, N., Loke, P. & Blaser, M. J. : Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014, 158 : 705-721
 
7) Matsuki, T., Yahagi, K., Mori, H., Matsumoto, H., Hara, T., Tajima, S., Ogawa, E, Kodarna, H., Yamamoto, K., Yamada, T., Matsumoto, S. &Kurokawa, K. : A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun 2016, 7 : 11939
 
8) Sela, D. A., Chapman, J., Adeuya, A., Kim, J. H., Chen, F., Whitehead, T. R., Lapidus, A., Rokhsar, D. S., Lebrilla, C. B., German, J. B., Price, N. P., Richardson, P. M. & Mills, D. A. : The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl. Acad. Sci. U. S. A. 2008, 105 : 18964-18969
 
9) Wada, J., Ando, T., Kiyohara, M., Ashida, H., Kitaoka, M., Yamaguchi, M., Kumagai, H., Katayama, T. & Yamamoto, K. : Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl Environ Microbiol 2008, 74 : 3996-4004
 
10) La Rosa, P. S., Warner, B. B., Zhou, Y., Weinstock, G. M, Sodergren, E., Hall-Moore, C. M, Stevens, H. J., Bennett, W. E., Jr., Shaikh, N., Linneman, L. A., Hoffmann, J. A., Hamvas, A., Deych, E, Shands, B. A., Shannon, W. D. & Tarr, P. I. : Patterned progression of bacterial populations in the premature infant gut. Proc. Natl. Acad. Sci. U. S. A. 2014, 111 : 12522-12527
 
11) Macfarlane, S. & Macfarlane, G. T. : Regulation of short-chain fatty acid production. Proc Nutr Soc 2003, 62 : 67-72
 
12) Asahara, T., Shimizu, K., Nomoto, K, Hamabata, T., Ozawa, A. & Takeda, Y. : Probiotic bifidobacteria protect mice from lethal infection with Shiga toxinproducing Escherichia coli O157 : H7. Infect. Immun. 2004, 72 : 2240-2247
 
13) Fukuda, S., Toh, H., Hase, K., Oshima, K, Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T., Taylor, T. D., Itoh, K., Kikuchi, J., Morita, H., Hattori, M. & Ohno, H. : Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469 : 543-547
 
14) Kimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A., Miyauchi, S., Kobayashi, M., Hirasawa, A. & Tsujimoto, G. : Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc. Natl. Acad. Sci. U. S. A. 2011, 108 : 8030-8035
 
15) Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., Xavier, R. J., Teixeira, M. M. & Mackay, C. R. : Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461 : 1282-1286
 

講演4. アジア マイクロビオーム プロジェクト : アジア人の食と健康のインターフェースとしての腸内フローラの理解に向けて

P.61 掲載の参考文献
1) Nakayama, J., Watanabe, K., Jiang, J., Matsuda, K, Chao, S. -H., Haryono, P., La-ongkham, O., Sarwoko, M. -A., Sujaya, I, I. N, Zhao, L., Chen, K. -T., Chen, Y. -P., Chiu, H. -H., Hidaka, T., Huang, N. -X., Kiyohara, C., Kurakawa, T., Sakamoto, N., Sonomoto, K, Tashiro, K. Tsuji, H., Chen, M. -J., Leelavatcharamas, V., Liao, C. -C., Nitisinprasert, S., Rahayu, E. S., Ren, F. -Z., Tsai, Y. -C., Lee, Y. -K. Diversity in gut bacterial community of school-age children in Asia Sci Rep., 2015, 5, 8397.
 
2) Nakayama, J., Yamamoto, A., Palermo-Conde, L. A., Higashi, K., Sonomoto, K., Tan, J., Lee, Y. -K. Impact of westernized diet on gut microbiota in children on Leyte island., Front Microbiol., 2017, 8, 197.
 
3) Ruengsomwong, S., Korenori, Y., Sakamoto, N., Wannissorn, B., Nakayama, J., Nitisinprasert, S. Microbial community of healthy Thai vegetarians and non-vegetarians, their core gut microbiota and pathogens risk., J. Microbiol. Biotechnol. 2016, 26, 1723-1735.
 
4) De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., Lionetti, P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa., Proc. Natl. Acad. Sci., 2010, 107, 14691-14696.
PubMed
5) Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M. Magris, M., Hidalgo, G., Baldassano, R. N. Anokhin, A. P. Heath, A. C., Warner, B., Reeder, J., Kuczynski, J., Caporaso, J. G., Lozupone, C. A., Lauber, C., Clemente, J, C., Knights, D., Knight, R., Gordon, J. I. Human gut microbiome viewed across age and geography., Nature 2012, 486, 222-227.
PubMed

講演5. 非感染性疾患におけるプロバイオティクスの効果

P.67 掲載の参考文献
1) Greer RL, Morgum A, Shulzhenko N. Bridging immunity and lipid metabolism by gut microbiota. J Allergy Clin Immunol 2013 ; 132 : 253-62.
PubMed
2) NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from l975 to 2014 : a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 2016 ; 387 : 1377-96.
 
3) Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr 2012 ; 96 : 544-51.
PubMed
4) Rautava S, Luoto R, Salminen S, Isolauri E. Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol 2012 ; 9 : 565-76.
PubMed
5) Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep 2016 ; 6 : 23129.
PubMed
6) Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010 ; 107 : 11971-5.
PubMed
7) Aakko J, Kumar H, Rautava S, et al. Human milk oligosaccharide categories define the microbiota composition in human colostrum. Benef Microbes 2017 24 ; 8 : 563-7.
 
8) Kumar H, du Toit E, Kulkarni A, et al. Distinct patterns in human milk microbiota and fatty acid profiles across specific geographic locations. FrontMicrobiol 2016 : 7 : 1619.
PubMed
9) Gomez-Gallego C, Kumar H, Garcia-Mantrana I, et al. Breast milk polyamines and microbiota interactions : impact of mode of delivery and geographical location. Ann Nutr Metab 2017 ; 70 : 184-90.
PubMed
10) Nagpal R, Tsuji H, Takahashi T, et al. Ontogenesis of the gut microbiota composition in healthy, full-term, vaginally born and breast-fed infants over the first 3 years of life : a quantitative bird's-eye view. Front Microbiol 2017 ; 8 : 1388.
 
11) Nagpal R, Kurakawa T, Tsuji H, et al. Evolution of gut Bifidobacterium population in healthy Japanese infants over the first three years of life : a quantitative assessment. Sci Rep 2017 ; 7 : 10097.
PubMed
12) Endo A, Partty A, Kalliomaki M, Isolauri E, Salminen S. Long-term monitoring of the human intestinal microbiota from the 2nd week to 13 years of age. Anaerobe 2014 ; 28 : 149-56.
 
13) Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004 ; 101 : 15718-23.
PubMed
14) Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007 ; 56 : 1761-72.
PubMed
15) Wankhade UD, Thakali KM, Shankar K. Persistent influence of maternal obesity on offspring health : Mechanisms from animal models and clinical studies. Mol Cell Endocrinol 2016 ; 435 : 7-19.
PubMed
16) Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008 ; 88 : 894-9.
PubMed
17) Kalliomaki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008 ; 87 : 534-8.
PubMed
18) Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S Isolauri E. Distinct patterns of neonatal gut microflora in infants developing or not developing atopy. J Allergy and Clin Immunol 2001 : 107 : 129-34.
PubMed
19) Hill C, Guarner F, Reid G, et al. Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014 ; 11 : 506-14.
PubMed
20) Kalliomaki M, Salminen S, Kero P, et al. Probiotics in primary prevention of atopic disease : a randomised placebo-controlled trial. Lancet 2001 ; 357 : 1076-9.
PubMed
21) Lundelin K, Poussa T, Salminen S, Isolauri E. Long-term safety and efficacy of perinatal probiotic intervention : evidence from a follow-up study of four randomized, double-blind, placebo-controlled trials. Pediatr Allerg Immunol 2017 ; 28 : 170-5.
 
22) Fiocchi A, Pawankar R, Cuello-Garcia C, et al. World Allergy Ogranization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P) : Probiotics. World Allergy Organ J 2015 ; 8 : 4-16.
 
23) Dahiya DK, Renuka, Puniya M, et al. Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics : a review. Front Microbiol 2017 ; 8 : 563.
PubMed
24) Luoto R, Kalliomaki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity : follow-up study from birth to 10 years. Int J Obes (Lond). 2010 ; 34 : 1531-7.
PubMed
25) Saez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, Plaza-Diaz J, Gil A. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease : a review of human clinical trials. Int J Mol Sci. 2016 ; 17 : 6.
PubMed
26) Zhang Q, Wu Y, Fei X. Effect of probiotics on body weight and body-mass index : a systematic review and meta-analysis of randomized, controlled trials. Int Food Sci Nutr 2015 ; 67 : 571-80.
 
27) Vinderola G, Gueimonde M, Gomez-Gallego C, Delfederico L, Salminen S. Correlation between and assays in selection of probiotics from traditional species of bacteria, Trends in Food Science & Technology 2017 ; 68 : 83-90.
 
28) Collado MC, Meriluoto J, Salminen S. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol. 2007 ; 45 : 454-60.
PubMed
29) Zhao L. The gut microbiota and obesity : from correlation to causality. Nat Rev Microbiol 2013 ; 11 : 639-47.
PubMed

書評

最近チェックした商品履歴

Loading...